Onkologie und Hämatologie | Zeitschrift memo - Magazine of European Medical Oncology Ausgabe 4/2021 share TEILEN Suchen insite SUCHEN Inhaltsverzeichnis (23 Artikel) 01.12.2021 | ASCO 2021 | editorial Best of ASCO 2021 Univ.-Prof. Dr. Ewald Wöll 01.12.2021 | editorial Practical issues in hematology Prof. Klaus Geissler MD 01.12.2021 | editorial Rare lung cancers—2021 update on challenges, advances, and opportunities Dr. Andreas Pircher Open Access 26.10.2021 | ASCO 2021 | short review ASCO 2021—an update on metastastic colorectal cancer Lukas Weiss MD, PhD PDF-Version jetzt herunterladen Zum Volltext Open Access 11.10.2021 | ASCO 2021 | short review ASCO 2021: Highlights in central nervous system tumors Maximilian J. Mair MD, Anna S. Berghoff MD, PhD PDF-Version jetzt herunterladen Zum Volltext Open Access 04.10.2021 | ASCO 2021 | short review Best of ASCO 2021: new data from triple-negative breast cancer Univ.-Prof. Dr. Christian Singer MPH PDF-Version jetzt herunterladen Zum Volltext Open Access 27.10.2021 | ASCO 2021 | short review ASCO 2021 highlights head and neck cancer: nasopharyngeal carcinoma Thorsten Fuereder MD PDF-Version jetzt herunterladen Zum Volltext 25.10.2021 | ASCO 2021 | short review Best of ASCO 2021—bladder cancer Karl Mayrhofer MD, Dora Niedersüß-Beke MD, MBA Open Access 08.10.2021 | ASCO 2021 | short review ASCO 2021–Gastroesophageal tumor highlights Aysegül Ilhan-Mutlu MD, PhD PDF-Version jetzt herunterladen Zum Volltext 21.10.2021 | ASCO 2021 | short review Ovarian cancer—ASCO annual meeting update 2021 Johannes Schöche, Kathrin Strasser-Weippl Open Access 18.10.2021 | ASCO 2021 | review ASCO 2021—selection of personal highlights in early stage non-small cell lung cancer Gudrun Absenger, PD Dr. Andreas Pircher PDF-Version jetzt herunterladen Zum Volltext 18.10.2021 | review Practical considerations for the management of immune thrombocytopenic purpura Michael Fillitz, Barbara Dixer, Felix Keil 12.10.2021 | short review Pancytopenia—a diagnostic challenge? Klaus Geissler 29.10.2021 | short review Laboratory thrombophilia screening: essentials for hematologists Paul A. Kyrle 18.06.2021 | original report Value of autophagy-related gene 5 (ATG5) expression as a prognostic marker in adults with newly diagnosed acute lymphoblastic leukaemia (ALL) Rasha I. Ibrahim, Haydi S. Mohamed, Mary G. Nagib, Hebatullah M. Fares, Alia M. Saeed 20.08.2021 | comment The double-edged sword of immune checkpoint inhibition in advanced staged thymic epithelial tumours Wolfgang Jungraithmayr MD PhD Open Access 17.08.2021 | short review Unresectable pleural mesothelioma—hope or still an unmet medical need? Priv.-Doz. Dr. Gudrun Absenger, Priv.-Doz. Dr. Angelika Terbuch PDF-Version jetzt herunterladen Zum Volltext Open Access 21.05.2021 | short review Neuroendocrine neoplasms of the lung: a pathology update Dr. Jasna Metovic MD, Dr. Marco Barella MD, Prof. Dr. Giuseppe Pelosi MD, MIAC PDF-Version jetzt herunterladen Zum Volltext 06.07.2021 | case report Detection of acquired resistance mutation ALK G1202R after treatment with alectinib and response of lorlatinib A case report Louisa Hempel, Jakob Molnar, Andreas Gaumann, Sebastian Robert, Josef Scheiber, Axel Kleespies, Kristina Riedmann, Susanne Schreiber, Beate Gandorfer, Armin Piehler, Dirk Hempel Open Access 20.08.2021 | case report Rare lung cancers—Primary pulmonary leiomyosarcoma: A case report Laurenz Nagl, Andreas Seeber, Gerlig Widmann, Katja Schmitz, Herbert Maier, Georg Pall, Dominik Wolf, Andreas Pircher PDF-Version jetzt herunterladen Zum Volltext Open Access 08.11.2021 | short review The value of immunotherapy in pediatric leukemia and lymphoma Elisabeth Salzer, Andishe Attarbaschi PDF-Version jetzt herunterladen Zum Volltext 20.09.2021 | case report Ponatinib and palbociclib combination in TKI-resistant CML—A case report Johannes B. Jaeger, Thomas Jaeger, Sandra Preuner, Petra Pusic, Isabella Sponseiler, Thomas Lion, Thomas Winder, Bernd Lorenz Hartmann 04.10.2021 | review Is thymus and activation-regulated chemokine a forgotten diagnostic and minimal residual disease marker in classical Hodgkin lymphoma? A chronological narrative literature review Wael Khair MD
